Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells

Wending Yang, Jason Monroe, Yonghong Zhang, David George, Eric Bremer, Honglin Li

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The proteasome-mediated protein degradation is critical for regulation of a variety of cellular processes, including cell cycle, cell death, differentiation and immune response. Proteasome inhibitors have recently been shown to be potent anti-cancer agents against a variety of cancer cells. Our study demonstrated that proteasome inhibitor MG132 (carbobenzoxy-l-leucyle-l-leucyl-l-leucinal) was a potent death-inducing agent for PC3 prostate cancer cells. MG132-induced cell death was partially inhibited by pan-caspase inhibitor zAVD-fmk and translational inhibitor cycloheximide. To understand the signaling pathways of proteasome inhibitor-induced cell death, we performed gene profiling study using Affymetrix human DNA microarrays to identify the genes whose expression was affected by proteasome inhibitor MG132 in PC3 cells. The genes with more than threefold increased expression induced by MG132 were functionally categorized into the following groups: heat shock and chaperone proteins, ubiquitination and protein degradation, transcription/translation factors, cell death and cell cycle arrest, signaling molecules and enzymes, and secreted cytokines. Among them, heat shock proteins and anti-oxidant enzymes may promote cell survival, while pro-death proteins such as GADD45B and STK17a may promote cell death. Interestingly, expression of a few autophagic genes was elevated by MG132 treatment. Furthermore, autophagy inhibitor 3-methyladenine partially inhibited MG132-induced cell death, indicating that autophagic cell death may contribute to MG132-induced cell death. Taken together, our results demonstrated that proteasome inhibition elicits activation of multiple signaling pathways in prostate cancer cells.

Original languageEnglish (US)
Pages (from-to)217-227
Number of pages11
JournalCancer Letters
Volume243
Issue number2
DOIs
StatePublished - Nov 18 2006

Fingerprint

Proteasome Endopeptidase Complex
Prostatic Neoplasms
Cell Death
Proteasome Inhibitors
Autophagy
Heat-Shock Proteins
Proteolysis
Genes
Caspase Inhibitors
Ubiquitination
Enzymes
Cycloheximide
Cell Cycle Checkpoints
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Oligonucleotide Array Sequence Analysis
Oxidants
Cell Differentiation
Neoplasms
Cell Survival
Cell Cycle

Keywords

  • Apoptosis
  • Autophagic cell death
  • Gene profiling
  • Proteasome inhibitor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. / Yang, Wending; Monroe, Jason; Zhang, Yonghong; George, David; Bremer, Eric; Li, Honglin.

In: Cancer Letters, Vol. 243, No. 2, 18.11.2006, p. 217-227.

Research output: Contribution to journalArticle

Yang, Wending ; Monroe, Jason ; Zhang, Yonghong ; George, David ; Bremer, Eric ; Li, Honglin. / Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. In: Cancer Letters. 2006 ; Vol. 243, No. 2. pp. 217-227.
@article{fd961ba9c14242acb9dc8e72e84ef20a,
title = "Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells",
abstract = "The proteasome-mediated protein degradation is critical for regulation of a variety of cellular processes, including cell cycle, cell death, differentiation and immune response. Proteasome inhibitors have recently been shown to be potent anti-cancer agents against a variety of cancer cells. Our study demonstrated that proteasome inhibitor MG132 (carbobenzoxy-l-leucyle-l-leucyl-l-leucinal) was a potent death-inducing agent for PC3 prostate cancer cells. MG132-induced cell death was partially inhibited by pan-caspase inhibitor zAVD-fmk and translational inhibitor cycloheximide. To understand the signaling pathways of proteasome inhibitor-induced cell death, we performed gene profiling study using Affymetrix human DNA microarrays to identify the genes whose expression was affected by proteasome inhibitor MG132 in PC3 cells. The genes with more than threefold increased expression induced by MG132 were functionally categorized into the following groups: heat shock and chaperone proteins, ubiquitination and protein degradation, transcription/translation factors, cell death and cell cycle arrest, signaling molecules and enzymes, and secreted cytokines. Among them, heat shock proteins and anti-oxidant enzymes may promote cell survival, while pro-death proteins such as GADD45B and STK17a may promote cell death. Interestingly, expression of a few autophagic genes was elevated by MG132 treatment. Furthermore, autophagy inhibitor 3-methyladenine partially inhibited MG132-induced cell death, indicating that autophagic cell death may contribute to MG132-induced cell death. Taken together, our results demonstrated that proteasome inhibition elicits activation of multiple signaling pathways in prostate cancer cells.",
keywords = "Apoptosis, Autophagic cell death, Gene profiling, Proteasome inhibitor",
author = "Wending Yang and Jason Monroe and Yonghong Zhang and David George and Eric Bremer and Honglin Li",
year = "2006",
month = "11",
day = "18",
doi = "10.1016/j.canlet.2005.11.033",
language = "English (US)",
volume = "243",
pages = "217--227",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells

AU - Yang, Wending

AU - Monroe, Jason

AU - Zhang, Yonghong

AU - George, David

AU - Bremer, Eric

AU - Li, Honglin

PY - 2006/11/18

Y1 - 2006/11/18

N2 - The proteasome-mediated protein degradation is critical for regulation of a variety of cellular processes, including cell cycle, cell death, differentiation and immune response. Proteasome inhibitors have recently been shown to be potent anti-cancer agents against a variety of cancer cells. Our study demonstrated that proteasome inhibitor MG132 (carbobenzoxy-l-leucyle-l-leucyl-l-leucinal) was a potent death-inducing agent for PC3 prostate cancer cells. MG132-induced cell death was partially inhibited by pan-caspase inhibitor zAVD-fmk and translational inhibitor cycloheximide. To understand the signaling pathways of proteasome inhibitor-induced cell death, we performed gene profiling study using Affymetrix human DNA microarrays to identify the genes whose expression was affected by proteasome inhibitor MG132 in PC3 cells. The genes with more than threefold increased expression induced by MG132 were functionally categorized into the following groups: heat shock and chaperone proteins, ubiquitination and protein degradation, transcription/translation factors, cell death and cell cycle arrest, signaling molecules and enzymes, and secreted cytokines. Among them, heat shock proteins and anti-oxidant enzymes may promote cell survival, while pro-death proteins such as GADD45B and STK17a may promote cell death. Interestingly, expression of a few autophagic genes was elevated by MG132 treatment. Furthermore, autophagy inhibitor 3-methyladenine partially inhibited MG132-induced cell death, indicating that autophagic cell death may contribute to MG132-induced cell death. Taken together, our results demonstrated that proteasome inhibition elicits activation of multiple signaling pathways in prostate cancer cells.

AB - The proteasome-mediated protein degradation is critical for regulation of a variety of cellular processes, including cell cycle, cell death, differentiation and immune response. Proteasome inhibitors have recently been shown to be potent anti-cancer agents against a variety of cancer cells. Our study demonstrated that proteasome inhibitor MG132 (carbobenzoxy-l-leucyle-l-leucyl-l-leucinal) was a potent death-inducing agent for PC3 prostate cancer cells. MG132-induced cell death was partially inhibited by pan-caspase inhibitor zAVD-fmk and translational inhibitor cycloheximide. To understand the signaling pathways of proteasome inhibitor-induced cell death, we performed gene profiling study using Affymetrix human DNA microarrays to identify the genes whose expression was affected by proteasome inhibitor MG132 in PC3 cells. The genes with more than threefold increased expression induced by MG132 were functionally categorized into the following groups: heat shock and chaperone proteins, ubiquitination and protein degradation, transcription/translation factors, cell death and cell cycle arrest, signaling molecules and enzymes, and secreted cytokines. Among them, heat shock proteins and anti-oxidant enzymes may promote cell survival, while pro-death proteins such as GADD45B and STK17a may promote cell death. Interestingly, expression of a few autophagic genes was elevated by MG132 treatment. Furthermore, autophagy inhibitor 3-methyladenine partially inhibited MG132-induced cell death, indicating that autophagic cell death may contribute to MG132-induced cell death. Taken together, our results demonstrated that proteasome inhibition elicits activation of multiple signaling pathways in prostate cancer cells.

KW - Apoptosis

KW - Autophagic cell death

KW - Gene profiling

KW - Proteasome inhibitor

UR - http://www.scopus.com/inward/record.url?scp=33749243499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749243499&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2005.11.033

DO - 10.1016/j.canlet.2005.11.033

M3 - Article

C2 - 16413676

AN - SCOPUS:33749243499

VL - 243

SP - 217

EP - 227

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -